169 related articles for article (PubMed ID: 15876155)
1. Selective agonists and antagonists to thyroid hormone action.
Kraiem Z
Thyroid; 2005 Apr; 15(4):336-9. PubMed ID: 15876155
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in thyroid research: selective thyroid hormone receptor modulators (STRMs).
Kraiem Z
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():257-60; discussion 260. PubMed ID: 16444167
[TBL] [Abstract][Full Text] [Related]
3. Thyromimetics: a review of recent reports and patents (2004 - 2009).
Hirano T; Kagechika H
Expert Opin Ther Pat; 2010 Feb; 20(2):213-28. PubMed ID: 20100003
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic applications of thyroid hormone analogs.
Brenta G; Danzi S; Klein I
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):632-40. PubMed ID: 17710084
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone analogues: where do we stand in 2013?
Meruvu S; Ayers SD; Winnier G; Webb P
Thyroid; 2013 Nov; 23(11):1333-44. PubMed ID: 23915136
[TBL] [Abstract][Full Text] [Related]
6. Bisphenol A acts differently from and independently of thyroid hormone in suppressing thyrotropin release from the bullfrog pituitary.
Kaneko M; Okada R; Yamamoto K; Nakamura M; Mosconi G; Polzonetti-Magni AM; Kikuyama S
Gen Comp Endocrinol; 2008 Feb; 155(3):574-80. PubMed ID: 17959175
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone antagonists: potential medical applications and structure activity relationships.
Malm J; Färnegârdh M; Grover GJ; Ladenson PW
Curr Med Chem; 2009; 16(25):3258-66. PubMed ID: 19548868
[TBL] [Abstract][Full Text] [Related]
8. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
9. New insights into thyroid hormone action.
Oetting A; Yen PM
Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):193-208. PubMed ID: 17574003
[TBL] [Abstract][Full Text] [Related]
10. Thyromimetics: a journey from bench to bed-side.
Tancevski I; Rudling M; Eller P
Pharmacol Ther; 2011 Jul; 131(1):33-9. PubMed ID: 21504761
[TBL] [Abstract][Full Text] [Related]
11. Selective thyromimetics: tissue-selective thyroid hormone analogs.
Scanlan TS; Yoshihara HA; Nguyen NH; Chiellini G
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):614-22. PubMed ID: 12825456
[TBL] [Abstract][Full Text] [Related]
12. Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosis.
Kitamura S; Kato T; Iida M; Jinno N; Suzuki T; Ohta S; Fujimoto N; Hanada H; Kashiwagi K; Kashiwagi A
Life Sci; 2005 Feb; 76(14):1589-601. PubMed ID: 15680168
[TBL] [Abstract][Full Text] [Related]
13. Analysis of thyroid hormone receptor betaA mRNA expression in Xenopus laevis tadpoles as a means to detect agonism and antagonism of thyroid hormone action.
Opitz R; Lutz I; Nguyen NH; Scanlan TS; Kloas W
Toxicol Appl Pharmacol; 2006 Apr; 212(1):1-13. PubMed ID: 16040072
[TBL] [Abstract][Full Text] [Related]
14. Selective thyroid hormone receptor modulators.
Yoshihara HA; Scanlan TS
Curr Top Med Chem; 2003; 3(14):1601-16. PubMed ID: 14683517
[TBL] [Abstract][Full Text] [Related]
15. [Harmful effects of common drugs on the visual apparatus. Hormones. II. Thyroid hormones, thyrotropin hormone and synthetic antithyroid drugs].
van Oye R
Bull Soc Belge Ophtalmol; 1972; 160(1):292-5. PubMed ID: 4114819
[No Abstract] [Full Text] [Related]
16. [Nipiopharmacology of thyroid hormones, thyreotrope hormone, hormones of the neuro-hypophisis and serotonin].
Cao A
Minerva Nipiol; 1967; 17(6):238-94. PubMed ID: 4184975
[No Abstract] [Full Text] [Related]
17. Cardiac specific effects of thyroid hormone analogues.
Danzi S; Klein I
Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.
Jakobsson T; Vedin LL; Parini P
Drugs; 2017 Oct; 77(15):1613-1621. PubMed ID: 28865063
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone excess and osteoporosis.
Leb G; Warnkross H; Obermayer-Pietsch B
Acta Med Austriaca; 1994; 21(2):65-7. PubMed ID: 7527991
[TBL] [Abstract][Full Text] [Related]
20. Cell type-dependent agonist/antagonist activities of polybrominated diphenyl ethers.
Nakamura N; Matsubara K; Sanoh S; Ohta S; Uramaru N; Kitamura S; Yamaguchi M; Sugihara K; Fujimoto N
Toxicol Lett; 2013 Nov; 223(2):192-7. PubMed ID: 24076165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
